APA (7. basım) Alıntı

Cerro-Herreros, E., González-Martínez, I., Moreno, N., Espinosa-Espinosa, J., Fernández-Costa, J., Colom-Rodrigo, A., . . . Artero, R. (2021). Preclinical characterization of antagomiR-218 as a potential treatment for myotonic dystrophy. Cell Press.

Chicago Style (17. basım) Atıf

Cerro-Herreros, E., et al. Preclinical Characterization of AntagomiR-218 as a Potential Treatment for Myotonic Dystrophy. Cell Press, 2021.

MLA (9th ed.) Atıf

Cerro-Herreros, E., et al. Preclinical Characterization of AntagomiR-218 as a Potential Treatment for Myotonic Dystrophy. Cell Press, 2021.